Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.70 |
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | PGR | P06401 | 3/20 | 0.68 |
| ▸ | AR | P10275 | 3/20 | 0.68 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.61 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 8/20 | 0.56 |
| ▸ | FNTA | P49354 | 1/20 | 0.56 |
| ▸ | FNTB | P49356 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1650395 | 0.98 | LMNA (0.72) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL10868391 | 0.98 | LMNA (0.72) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL144436 | 0.98 | LMNA (0.72) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL8859777 | 0.92 | LMNA (0.67) | LMNAMEN1KMT2ATDP1PGR | |
| Megestrol Acetate SCHEMBL5599601 | 0.88 | AR (0.81) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL11512435 | 0.87 | FNTA (0.73) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL11513690 | 0.87 | LMNA (0.58) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL11513687 | 0.87 | LMNA (0.58) | LMNAMEN1KMT2ATDP1PGR | |
| Acetic Acid SCHEMBL25192781 | 0.83 | PGR (0.96) | LMNAMEN1KMT2ATDP1PGR | |
| Acetic Acid SCHEMBL28104035 | 0.82 | PGR (0.94) | LMNAMEN1KMT2ATDP1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11290 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| EP-4647069-A1 | DRUGS AND COMPOSITIONS FOR USE IN THE TREATMENT OF RETT SYNDROME | UNIVERSITA' DEGLI STUDI DI TRIESTE (IT) | 2025-11-12 | — | — | EP | claimed |
| WO-2025151711-A1 | NUCLEIC ACID VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025151713-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | claimed |
| US-20250222082-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | ARKEA BIO CORP (US) | 2025-07-10 | — | — | US | claimed |
| WO-2025128700-A1 | CELL-BASED VACCINES | Arkea Bio Corp. (US) | 2025-06-19 | — | — | WO | claimed |
| WO-2025085377-A1 | USE OF ZOALENE IN LIVESTOCK | ZOETIS SERVICES LLC (US) | 2025-04-24 | — | — | WO | claimed |
| EP-4524131-A1 | SMALL MOLECULES FOR TREATING CANCER, INHABITING CHEMOKINE ACTIVITY AND/OR INDUCING CELL DEATH | AlonBio Ltd. (IL) | 2025-03-19 | — | — | EP | claimed |
| CN-116217648-B | Preparation and purification method of melengestrol acetate | 湖南科益新生物医药有限公司 | 2025-01-28 | — | — | CN | claimed |
| US-5227167-A | LONG-TERM DELIVERY DEVICE INCLUDING HYDROPHOBIC LOADING DOSE | ALZA CORPORATION (US) | 1993-07-13 | — | — | US | claimed |
| WO-1992022346-A1 | LONG-TERM DELIVERY DEVICE INCLUDING HYDROPHOBIC LOADING DOSE | ALZA CORPORATION (US) | 1992-12-23 | — | — | WO | claimed |
| EP-0510062-A1 | LONG-TERM DELIVERY DEVICE INCLUDING LOADING DOSE. | ALZA CORP (US) | 1992-10-28 | — | — | EP | claimed |
| EP-0491803-A1 | IMPLANTABLE DELIVERY DISPENSER. | ALZA CORP (US) | 1992-07-01 | — | — | EP | claimed |
| US-5112614-A | IMPLANTABLE DELIVERY DISPENSER | ALZA CORPORATION (US) | 1992-05-12 | — | — | US | claimed |
| EP-0463454-A2 | Transdermal administration to humans and animals | DERMAMED (IL) | 1992-01-02 | — | — | EP | claimed |
| WO-1991010423-A1 | LONG-TERM DELIVERY DEVICE INCLUDING LOADING DOSE | ALZA CORPORATION (US) | 1991-07-25 | — | — | WO | claimed |
| WO-1991004016-A1 | IMPLANTABLE DELIVERY DISPENSER | ALZA CORPORATION (US) | 1991-04-04 | — | — | WO | claimed |
| EP-0179496-A1 | 16-Sulfinylmethyl-steroids, their preparation and use | THE UPJOHN COMPANY (US) | 1986-04-30 | — | — | EP | claimed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | claimed |